ArticleTranslational oncology2022

Combination of CTLA-4 blockade with MUC1 mRNA nanovaccine induces enhanced anti-tumor CTL activity by modulating tumor microenvironment of triple negative breast cancer.

Xuan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.